|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.250 USD | +4.37% |
|
+9.38% | -64.72% |
| 07-09 | Seres Therapeutics Announces Early Clinical Data Showing Potential For SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis | CI |
| 07-08 | Seres Therapeutics, Inc. - Special Call |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +4.37% | +9.38% | -32.17% | -31.73% | -64.72% | -64.48% | -94.69% | -96.30% | -97.18% | 48.71M | |
| +10.00% | +14.90% | +13.88% | +29.03% | +55.95% | +53.89% | +87.07% | -11.03% | - | 56.7B | |
| +0.80% | -5.70% | -12.37% | +6.37% | +1.56% | +23.89% | +62.65% | +175.24% | +5,547.79% | 51.97B | |
| -0.98% | -1.19% | -6.35% | -8.05% | -4.04% | -16.98% | -14.21% | -77.96% | - | 23.33B | |
| +0.30% | -5.17% | -11.51% | -29.47% | -43.26% | -11.23% | +349.07% | +298.67% | +739.71% | 21.34B | |
| +1.73% | -1.57% | +0.51% | +9.99% | -7.35% | +32.81% | -25.80% | -35.90% | +52.93% | 17.44B | |
| +4.29% | +8.97% | -3.39% | +108.96% | +186.76% | +200.03% | +341.85% | +1,482.71% | +706.29% | 14.77B | |
| +2.49% | -0.76% | -5.67% | +8.10% | +25.91% | +14.04% | +615.65% | - | - | 14.53B | |
| +1.71% | -0.90% | +0.27% | +26.78% | +27.77% | +52.13% | +176.27% | +233.53% | +405.87% | 13.84B | |
| +4.16% | +4.44% | +6.67% | +17.28% | +34.95% | +444.12% | +183.06% | +35.50% | +1,418.47% | 12.12B | |
| +5.30% | -5.80% | -3.89% | -2.14% | -12.84% | +62.62% | +160.98% | +500.09% | +6,852.88% | 11.14B | |
| +5.48% | +9.64% | -10.77% | -18.96% | -21.33% | -53.07% | +609.28% | +73.74% | +95.20% | 10.41B | |
| +2.83% | -1.06% | -9.11% | +19.02% | +23.72% | +114.90% | +136.85% | +166.38% | +562.82% | 10.38B | |
| +0.12% | 0.00% | +98.58% | +103.30% | +80.15% | +197.17% | +348.45% | +377.56% | - | 8.83B | |
| +10.54% | +4.98% | +21.14% | +51.80% | +220.33% | +549.38% | +774.32% | -36.40% | -12.37% | 8.35B | |
| +2.17% | +0.16% | -6.34% | -6.50% | +18.53% | +62.19% | +10.13% | +138.30% | - | 7.73B | |
| +2.36% | -0.48% | -6.26% | -15.28% | +14.38% | +30.09% | +119.60% | -16.78% | - | 7.71B | |
| -2.80% | -0.29% | -26.38% | -6.46% | +251.01% | +188.38% | +245.77% | -37.27% | - | 7.49B | |
| +1.14% | -1.23% | +0.35% | +15.63% | +8.10% | +14.35% | +62.89% | +10.84% | +205.34% | 7.26B | |
| +2.59% | -6.64% | -17.01% | +17.30% | +4.29% | +10.08% | +373.08% | +286.55% | - | 7.05B | |
| Average | +3.02% | -0.02% | -0.49% | +14.75% | +39.99% | +95.22% | +226.11% | +182.50% | +1,373.15% | 15.62B | |
| Weighted average by Cap. | +3.47% | +0.54% | +0.30% | +15.94% | +34.24% | +75.08% | +187.35% | +173.97% | +2,361.23% |
- Stock Market
- Stocks
- MCRB Stock
- Sector Seres Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
